Skip to content
healthcare.dev
Get a free key

CETIRIZINE HYDROCHLORIDE 10 MG

NDC 66424-564, CETIRIZINE HYDROCHLORIDE, tablet, from SDA Laboratories, Inc..

Product NDC
66424-564
Status
Listed
Labeler
SDA Laboratories, Inc.
Dosage form
TABLET
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
ANDA
Application
ANDA209274
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/66424-564 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • CETIRIZINE HYDROCHLORIDE10 mg/1

Pharmacologic classes

Histamine H1 Receptor Antagonists [MoA]; Histamine-1 Receptor Antagonist [EPC]

Package NDCNDC-11Package
66424-564-0166424056401100 TABLET in 1 BOTTLE (66424-564-01)
66424-564-0566424056405500 TABLET in 1 BOTTLE (66424-564-05)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 66424-564 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/66424-564 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 66424-564. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.